Market Research Report Store Plexxikon Inc - Pharmaceuticals & Healthcare - Dea

Market Research Report Store has been recently published a fresh report"Plexxikon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile-Market Research Report Store＂.It is a professional and in-depth study. Complete Report Available at: @ https://www.marketresearchreportstore.com/ Request a sample, click here [email protected] Description Plexxikon Inc (Plexxikon), a subsidiary of Daiichi Sankyo Company Ltd is a drug discovery company that concentrates on discovery and development of novel, small molecules. The company’s pipeline products include PLX3397 to treat adjuvant glioblastoma, neoadjuvant breast, melanoma and solid tumors; PLX7486 to treat pancreatic and solid tumors; PLX 9486 to treat gastrointestinal stromal tumor and KIT-Mutant tumors; and PLX8394 to treat BRAF-Mutant tumors. It conducts clinical trials to evaluate a novel drug or combination of drugs or the new use of a marketed drug. Plexxikon uses its scaffold-like screening library to develop novel drugs. The company conducts research in collaboration with academic and clinical researchers to develop new therapies. Plexxikon is headquartered in Berkeley, California, the US. Plexxikon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. Scope